HOME >> BIOLOGY >> NEWS
Longer-term, moderate exercise improves immune activity

Older men and women who performed moderate resistance exercise at home 30 minutes a day, three times a week, for eleven months, showed a significant increase in natural killer cell activity, the immune system's first line of defense against viral infection, according to a study by researchers at Acadia University in Nova Scotia. The sustained exercise may be the key, say the researchers, since earlier studies using shorter periods of up to three months did not find this significant increase in immune system activity with resistance training.

In addition to enhanced immune response, the adults also showed significant improvements in muscle strength and lipid profiles, with decreased total cholesterol and LDL concentrations.

Jennifer DiPenta, a student working in the labs of Dr. Rene J. L. Murphy and Dr. Julia Green-Johnson, reported the study at Experimental Biology 2004, as part of the scientific sessions of The American Physiological Society.

Baseline immunological and physiological functions as well as lipid profiles were obtained from 10 men and 12 women, ages 54 to 82 years (median age 63.5), all retired. They then were trained in simple, moderate intensity resistance exercises, involving tubing and exercise balls, which they could do alone at home. During the next eleven months, the participants were monitored with bi-weekly phone calls and monthly home visits, during which the programs were altered, based on their abilities. At the end of approximately 11 months of training, they returned to the Centre of Lifestyle Studies at Acadia University for another series of physical and immune function tests.

Muscle strength increased significantly. There were no changes in weight, but total cholesterol and plasma LDL decreased significantly (HDL remained unchanged). To measure immune activity, lymphocytes from each participant were incubated with K562 tumor cells known to be targeted by natural killer cells. After eleven months of par
'"/>

Contact: Sarah Goodwin
eb4press@bellsouth.net
770-270-0989
Federation of American Societies for Experimental Biology
19-Apr-2004


Page: 1 2

Related biology news :

1. FDA approves Raptiva (efalizumab) for chronic moderate-to-severe plaque psoriasis
2. NIH told regular and moderate exposure to sunlight is the key to preventing chronic disease
3. New study ties moderate beer drinking to lower heart attack risk
4. Light to moderate drinking during pregnancy can affect adolescent growth
5. Actonel significantly reduced moderate and severe vertebral fractures
6. Even moderate caloric restriction lowers cancer risk in mice
7. Women who drink moderately do not face a longer wait to become pregnant
8. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
9. Integrative biology of exercise APS Intersociety meeting October 6-9, 2004 in Austin
10. Joslin Diabetes Center releases new low impact exercise video
11. Heat and exercise alone may not determine how much we sweat

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
Breaking Biology Technology:
Cached News: